Alx Oncology Holdings Inc (ALXO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.8301 -0.0013 (-0.16%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.8701 +0.0400 (+4.82%) 17:58 ET
for Fri, Mar 14th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 30,613 | 32,567 | 41,525 | 37,762 | 48,023 |
| Operating Income | -30,613 | -32,567 | -41,525 | -37,762 | -48,023 |
| Interest Expense | 427 | 446 | 429 | 427 | 415 |
| Other Income | 1,877 | 2,306 | 2,555 | 2,608 | 2,966 |
| Pre-tax Income | -29,163 | -30,707 | -39,399 | -35,581 | -45,472 |
| Net Income Continuous | -29,163 | -30,707 | -39,399 | -35,581 | -45,472 |
| Net Income | $-29,163 | $-30,707 | $-39,399 | $-35,581 | $-45,472 |
| EPS Basic Total Ops | -0.53 | -0.58 | -0.76 | -0.71 | -0.92 |
| EPS Basic Continuous Ops | -0.53 | -0.58 | -0.76 | -0.71 | -0.93 |
| EPS Diluted Total Ops | -0.53 | -0.58 | -0.76 | -0.71 | -0.92 |
| EPS Diluted Continuous Ops | -0.53 | -0.58 | -0.76 | -0.71 | -0.93 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.58 | -0.76 | -0.71 | -0.93 |
| EBITDA(a) | $-31,067 | $-33,327 | $-42,556 | $-39,037 | $-49,633 |